iCoreConnect Inc. Common stock (ICCT) - Cash Flow Conversion Efficiency
Based on the latest financial reports, iCoreConnect Inc. Common stock (ICCT) has a cash flow conversion efficiency ratio of 0.083x as of September 2024. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-250.46K) by net assets ($-3.02 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See ICCT equity to assets ratio to measure how much of total assets are equity-financed.
iCoreConnect Inc. Common stock - Cash Flow Conversion Efficiency Trend (2006–2023)
This chart illustrates how iCoreConnect Inc. Common stock's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check ICCT cash flow quality score to evaluate the quality of earnings relative to operating cash generation.
iCoreConnect Inc. Common stock Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of iCoreConnect Inc. Common stock ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Calviks AB (publ)
ST:TENEO
|
0.058x |
|
CPD SA
WAR:CPD
|
-0.023x |
|
Geekco Technologies Corp
V:GKO
|
0.017x |
|
IT Tech Packaging Inc
NYSE MKT:ITP
|
0.010x |
|
Conico Ltd
AU:CNJ
|
-0.265x |
|
Western Yilgarn NL
AU:WYX
|
-0.157x |
|
WesCan Energy Corp
V:WCE
|
0.254x |
|
Spectur Ltd
AU:SP3
|
-0.224x |
Annual Cash Flow Conversion Efficiency for iCoreConnect Inc. Common stock (2006–2023)
The table below shows the annual cash flow conversion efficiency of iCoreConnect Inc. Common stock from 2006 to 2023. For the full company profile with market capitalisation and key ratios, see market value of iCoreConnect Inc. Common stock.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2023-12-31 | $4.44 Million | $-8.82 Million | -1.986x | -490.21% |
| 2022-12-31 | $-2.50 Million | $-1.27 Million | 0.509x | +117.66% |
| 2021-12-31 | $1.01 Million | $-2.90 Million | -2.881x | -242.62% |
| 2020-12-31 | $-628.94K | $-1.27 Million | 2.020x | +156.35% |
| 2019-12-31 | $465.00K | $-1.67 Million | -3.585x | -274.42% |
| 2018-12-31 | $-958.00K | $-1.97 Million | 2.055x | +36.79% |
| 2017-12-31 | $-1.18 Million | $-1.77 Million | 1.503x | +94.20% |
| 2016-12-31 | $-2.26 Million | $-1.75 Million | 0.774x | +521.11% |
| 2015-12-31 | $-12.96 Million | $-1.61 Million | 0.125x | -3.24% |
| 2013-12-31 | $-12.79 Million | $-1.65 Million | 0.129x | +86.80% |
| 2012-12-31 | $-7.92 Million | $-545.84K | 0.069x | -86.09% |
| 2011-12-31 | $-2.57 Million | $-1.27 Million | 0.495x | +2.49% |
| 2010-12-31 | $-3.56 Million | $-1.72 Million | 0.483x | +117.94% |
| 2009-12-31 | $941.34K | $-2.54 Million | -2.694x | -387.89% |
| 2008-12-31 | $4.11 Million | $-2.27 Million | -0.552x | -21.84% |
| 2006-12-31 | $7.46 Million | $-3.38 Million | -0.453x | -- |
About iCoreConnect Inc. Common stock
iCoreConnect Inc., a cloud-based software and technology company, provides Health Insurance Portability and Accountability Act (HIPAA) compliant cloud-based software as a service (SaaS) in the United States. The company's products include iCoreRx, a HIPAA compliant electronic prescription software; iCorePDMP, a solution that checks the patient's Prescription Drug Monitoring Program (PDMP) history… Read more